You are here

Vitae

Allergan: How Will the Purchase of Vitae Pharmaceuticals Inc Affect it?

Bidness, ETC

Thu, 09/15/16 - 07:17 pm

Allergan to acquire Vitae Pharma in an all-cash deal valued at about $639 million

Marketwatch

Wed, 09/14/16 - 09:51 am

autoimmune disease

4 Key Biopharma Movers of the Past Week

24/7 Wall St

Sun, 03/20/16 - 01:34 pm

Bio Blast Pharma

3 Top Biopharma Movers of the Past Week

24/7 Wall St

Sun, 03/6/16 - 11:31 am

Juno Therapeutics

Vitae tanks after cutting its psoriasis trial short, stoking safety concerns

Fierce Biotech

Sat, 03/5/16 - 10:00 am

clinical trials

Biotechs Coming Off One Of The Busiest Weeks In Recent Memory

Yahoo/Benzinga

Tue, 09/15/15 - 09:04 am

Gilead Sciences

Clovis Oncology

Bristol-Myers Squibb

Tetraphase Pharmaceuticals

This Past Week’s Top 5 Biotech Movers

24/7 Wall St

Sat, 09/12/15 - 01:31 pm

Akebia Therapeutics

Clovis Oncology

Mirati Therapeutics

Vitae and Boehringer Get on BACE

InVivo

Mon, 06/15/09 - 10:44 am

Boehringer Ingelheim

Alzheimer's disease